Cardlytics Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $169.1M-33.9% YoYTTM through 30 Jun 2026
Net Income -$100.3MTTM through 30 Jun 2026
Free Cash Flow $463KTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 44.8% |
| EBITDA Margin | -43.6% |
| Operating Margin | -43.6% |
| Net Margin | -59.3% |
Returns
-36.2%ROA
Balance Sheet Health
Debt / Equity-32.10x
Current Ratio1.75x
Net Debt$160.2M
Cash & Equivalents$28M
Quality Metrics
Altman Z-Score-8.85
Piotroski F-Score4 / 9
FCF Margin0.3%
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $233.3M
Diluted EPS-$1.95TTMFY2025: $-1.95
Dividend
No dividend
Capital Allocation
R&D Spend$31.6M
Capex Intensity0.0%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.